文献速递头颈外科

头颈癌临床试验中患者报告吞咽困难核心结局集:一项国际多利益相关方德尔菲研究

A core outcome set for patient-reported dysphagia for use in head and neck cancer clinical trials: An international multistakeholder Delphi study.
PubMed 文献 · Head Neck · 2024-01-10

本研究通过两轮德尔菲法,纳入来自9个国家的45名头颈癌临床医生、研究者、患者和照护者,旨在建立头颈癌临床试验中患者报告吞咽困难的核心结局集(COS)。第一轮排除40个条目、64个进入第二轮,最终形成包含吞咽困难症状、健康状况和生活质量3个域的7个结局COS。作者建议在涉及头颈癌患者的临床试验中纳入这7个核心概念,以促进治疗比较和数据合成。

要点

  • 两轮德尔菲法在9个国家45名头颈癌利益相关方中达成共识。
  • 最终COS包含7个结局,覆盖吞咽困难症状、健康状况和生活质量3个域。
  • 作者建议头颈癌临床试验纳入这7个核心概念以促进治疗比较和数据合成。

核心结论

  • 本研究在头颈癌利益相关方中就头颈癌临床试验必需的吞咽困难患者报告结局达成共识。
  • 作者建议在涉及头颈癌患者的临床试验中纳入这7个核心概念,以促进治疗比较和数据合成。

研究设计与样本

  • 采用两轮德尔菲技术,纳入头颈癌临床医生、研究者、患者和照护者样本。
  • 第一轮中参与者对条目重要性进行5分制评分,评分≥4且>70%的条目进入第二轮。
  • 第二轮召开共识会议处理意见不一的条目,并对剩余条目完成德尔菲调查。
  • 评分≥4且>70%的条目形成最终核心结局集(COS)。

主要发现

  • 共招募来自9个国家的45名参与者。
  • 第一轮后排除40个条目,64个条目进入第二轮。
  • 第二轮后建立包含7个结局的COS,涵盖吞咽困难症状、健康状况和生活质量3个域。

关键数值与推荐

  • 条目重要性评分≥4且>70%参与者认可方进入下一轮并形成最终COS。
  • 最终COS包含7个结局,分属吞咽困难症状、健康状况和生活质量3个域。

临床怎么用

  • 作者建议在涉及头颈癌患者的临床试验中纳入这7个核心概念,以促进治疗比较和数据合成。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measuring dysphagia-related patient-reported outcomes (PROs) in Head and Neck Cancer (HNC) patients is challenging due to dysphagia's multidimensional impact, causing inconsistency in outcome reporting. To address this issue, this study derived a consensus-based core outcome set (COS) for patient-reported dysphagia in HNC clinical trials where swallowing is a primary or secondary endpoint. METHODS: A sample of HNC clinicians, researchers, patients, and caregivers participated in a 2-Round Delphi technique. A Delphi survey, containing a comprehensive list of dysphagia-related PROs, was developed. In Round 1, participants rated item importance on a 5-point scale. Items rated ≥4 by >70% advanced to Round 2, where a consensus meeting addressed items with varied opinions, and the Delphi survey with remaining items was completed. Items rated ≥4 by >70% formed the final COS. RESULTS: Forty-five participants from nine countries were recruited. After Round 1, 40 items were excluded and 64 advanced to Round 2. After Round 2, a 7-outcome COS was established, comprising the domains of dysphagia symptoms, health status and quality of life. CONCLUSION: This study achieved consensus among HNC stakeholders on essential dysphagia PROs for HNC clinical trials. It is advisable to include these 7-core concepts in clinical trials involving people with HNC to facilitate treatment comparisons and data synthesis.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Manduchi B, Fitch MI, Ringash JG, et al. A core outcome set for patient-reported dysphagia for use in head and neck cancer clinical trials: An international multistakeholder Delphi study. Head Neck. 2024. PMID: 38204219. doi:10.1002/hed.27626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。